glp-1 drugs weight loss effectiveness without diabetes Agonists Market Report, 2025-2030 Understanding Weight Loss Medications: GLP-1

Retatrutide is not approved for clinical use as of 2026

Allergic Reactions or Adverse Effects: Some patients might experience allergic reactions or adverse effects from Zepbound, potentially impacting their vision

doi: 10.1016/j.jhep.2024.07.006, PMID: [DOI] [PubMed] [Google Scholar] 95

ASMBS+3EurekAlert!+3News-Medical+3 Thus, while GLP-1s are powerful tools, for those seeking the greatest, most durable results or with advanced metabolic disease, surgery often remains superior

Prescribing decisions are made by licensed providers through OpenLoop Healthcare Partners, PC based on independent medical evaluation

Metabolic Messengers: glucagon-like peptide 1